EZZ Life Science (ASX: EZZ) — Perfil da empresa, notícias e dados financeiros
EZZ Life Science is a genomic life sciences company headquartered in Lidcombe, Australia, focused on advancing quality of life and human health.
EZZ Life Science
EZZ Life Science is a genomic life sciences company headquartered in Lidcombe, Australia, focused on advancing quality of life and human health. The company formulates, manufactures, and distributes science-backed health, wellness, and consumer products designed to address various health challenges and support healthy ageing. Operating an omnichannel distribution model, the business markets proprietary products under its EZZ brand and serves as an exclusive distributor for EAORON skincare solutions. Its sales network extends across major geographic regions including Australia, New Zealand, China, and expanding international markets through e-commerce platforms, retail networks, and supermarket channels.
Resumo
Operações
Produtos e/ou serviços de EZZ Life Science
- Genomic Health Supplements: Formulating and supplying consumer dietary supplements targeting anti-ageing, cellular health, immune function, and weight management. These therapeutic products are distributed through cross-border e-commerce platforms, community pharmacy networks, and specialized health retailers worldwide.
- Third-Party Skincare Distribution: Managing exclusive distribution rights for imported facial care solutions across Australia and New Zealand. Operations encompass delivering hyaluronic acid serums, face masks, and skin creams to national pharmacy chains, supermarkets, and travel retail hubs.
- Functional Personal Care Products: Formulating and marketing branded personal care solutions, including scalp treatments, hair care, and dermatological products. Items are sold through digital direct-to-consumer storefronts, digital social commerce channels, and domestic health and beauty retailers.
- Cross-Border E-Commerce Operations: Directing digital sales and marketing channels across major East Asian e-commerce marketplaces, including Tmall Global, Douyin, and JD.com. Operations distribute health and personal care products directly to overseas consumers.
- Domestic Supermarket and Pharmacy Distribution: Supplying health and wellness lines across mainstream Australian retail networks. Distribution agreements cover major national supermarket chains and digital grocery platforms, alongside independent pharmacies and health stores across Australia.
- Genomic Research and Formulations: Partnering with tertiary research institutions and biotechnology groups to research bioactive compounds. Operations focus on translating genomic research insights into commercially available nutritional supplements targeting healthy ageing and metabolic support.
equipe executiva do EZZ Life Science
- Qizhou QinCo-Founder, COO, CEO & Executive Director
- Anthony GuarnaChief Financial Officer
- Glenn CrossChief Strategy Officer
- Christina ChenExecutive Director
- Jay StephensonCompany Secretary
- James HudsonDirector of Corporate Affairs
Histórico de dividendos
Dividendos por ação pagos pela EZZ Life Science , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2025 | A$0.0200 | A$0.0200 | — | A$0.0400 |
| FY2024 | A$0.0200 | A$0.0150 | — | A$0.0350 |
| FY2023 | A$0.0100 | A$0.0098 | — | A$0.0198 |
| FY2022 | A$0.0045 | — | — | A$0.0045 |
| FY2021 | A$0.0045 | — | — | A$0.0045 |
Principais indicadores financeiros
Resultados divulgados pela EZZ Life Science , em AUD.
- Cap. de mercado
- 14,6 mi
- Receita (TTM)
- 46,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.1
- Dividend yield
- 0.0%
- Margem de lucro
- -11.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 46,3 mi | -6,6 mi | -5,3 mi | |
| 66,9 mi | 9,9 mi | 6,7 mi | |
| 66,4 mi | 9,7 mi | 7 mi | |
| 37,1 mi | 4,6 mi | 3,6 mi |